Verastem Oncology to Participate in Upcoming Investor Conferences
May 01 2023 - 7:00AM
Business Wire
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company
committed to advancing new medicines for patients with cancer,
today announced that the Company will participate in the following
upcoming investor conferences:
- JMP Securities Life Sciences Conference; podium presentation on
Tuesday, May 16, 2023 at 1:00 p.m. ET
- RBC Capital Markets Global Healthcare Conference; fireside chat
on Wednesday, May 17, 2023 at 2:05 p.m. ET
A live webcast of the presentation and fireside chat will be
available on the investors section of the Company’s website at
www.verastem.com. An archived replay of the presentation and
fireside chat will be made available on the same website for
approximately 90 days following each event.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a development-stage
biopharmaceutical company committed to the development and
commercialization of new medicines to improve the lives of patients
diagnosed with cancer. Our pipeline is focused on novel small
molecule drugs that inhibit critical signaling pathways in cancer
that promote cancer cell survival and tumor growth, including
RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition. For
more information, please visit www.verastem.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230501005068/en/
Investors: Dan Calkins +1 781-469-1694
dcalkins@verastem.com
Nate LiaBraaten +1 212-600-1902 nate@argotpartners.com
Media: Lisa Buffington +1 (781) 292-4205
lbuffington@verastem.com
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Jul 2023 to Jul 2024